Delisting riskPopularity #3,750
DataMEDS AI (MEDS)
Pharmaceutical distributor, pharmacy operator and prescription-routing technology provider.
$3.85
vs last close−0.42 (−9.94%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 8 | 10 | 6 | 12 | 11 | 8 | 3 | 2 | 2 | 2 |
| Cost of revenue | 32 | 7 | 9 | 6 | 12 | 10 | 7 | 3 | 12 | 1 | 2 |
| Gross profit | 3 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | −10 | 0 | 0 |
| 13 | 2 | 4 | 2 | 4 | 32 | 6 | 32 | 3 | 6 | 7 | |
| 8 | 2 | 2 | 2 | 4 | 31 | 5 | 31 | 4 | 6 | 7 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
| General & administrative | 8 | 2 | 2 | 0 | 0 | 31 | 5 | 30 | 4 | 5 | 7 |
| Other expenses | 5 | 0 | 2 | 0 | 0 | 1 | 1 | 1 | −2 | 0 | 0 |
| Operating income | −10 | −1 | −2 | −2 | −4 | −31 | −6 | −32 | −13 | −6 | −7 |
| −1 | 0 | 0 | 0 | −1 | −1 | −1 | −3 | −15 | −2 | −11 | |
| Interest expense | 2 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Income before tax | −12 | −2 | −2 | −2 | −4 | −32 | −7 | −34 | −28 | −8 | −18 |
| Net income from continuing operations | −12 | −2 | −2 | −2 | −4 | −32 | −7 | −34 | −28 | −8 | −18 |
| Net income | −12 | −2 | −2 | −2 | −4 | −32 | −7 | −34 | −28 | −8 | −18 |
| EPS, basic | −$12.60 | −$1.82 | −$0.56 | −$1.80 | −$4.17 | −$31.00 | −$5.50 | −$23.00 | −$13.50 | −$3.50 | −$7.13 |
| EPS, diluted | −$12.60 | −$1.82 | −$0.56 | −$1.80 | −$4.17 | −$31.00 | −$5.50 | −$23.00 | −$13.50 | −$3.50 | −$7.13 |
| Weighted average shares, basic | — | — | — | 1 | 1 | — | — | — | 1 | 2 | 3 |
| Weighted average shares, diluted | — | — | — | 1 | 1 | — | — | — | 1 | 2 | 3 |
| EBITDA | −5 | −1 | 0 | −1 | −3 | −31 | −5 | −32 | −12 | −5 | −7 |
| Depreciation & amortization | 5 | 0 | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| EBIT | −10 | −1 | −2 | −2 | −4 | −31 | −5 | −33 | −13 | −6 | −7 |
